Medipally Ajay, Xiao Min, Satoskar Anjali A, Biederman Laura, Ivanov Iouri, Mikhalina Galina, Brodsky Sergey
Department of Pathology, The Ohio State University Wexner Medical Center, Columbus, USA.
Department of Pathology, Nationwide Children's Hospital, Columbus, OH, USA.
Can J Kidney Health Dis. 2023 Mar 16;10:20543581231160507. doi: 10.1177/20543581231160507. eCollection 2023.
We have previously demonstrated that excessive anticoagulation with warfarin or dabigatran may result in acute kidney injury with red blood cell (RBC) tubular casts in some patients with chronic kidney disease, and this condition was named anticoagulant-related nephropathy (ARN). 5/6 nephrectomy (5/6NE) rats treated with warfarin or dabigatran reproduce the main pathologic features of human ARN. We had reported that 5/6NE C57BL/6 mice only partially develop ARN with increased serum creatinine and hematuria but no RBC tubular casts in the kidney.
The aim of this study was to investigate whether ARN can develop in 5/6NE 129S1/SvImJ mice.
5/6NE was performed in 129S1/SvImJ mice. Three weeks after 5/6NE, mice were treated with warfarin (1.0 and 1.5 mg/kg/day) or vehicle for 7 days. Serum creatinine, hematuria, and prothrombin time (PT) were monitored daily. Renal morphology was evaluated at the end of the studies.
Treatment with warfarin resulted in PT elevation 2 to 3 folds from baseline (1.0 mg/kg/day warfarin) and 4 to 5 folds from baseline (1.5 mg/kg/day warfarin) by day 7. Serum creatinine and hematuria elevated by day 7 in a dose-dependent manner. Histologically, 2 of 8 (25%) 5/6NE mice had RBCs in the tubules, and there was acute tubular epithelial cell injury in all warfarin-treated 5/6NE 129S1/SvImJ mice.
Our findings suggest that 129S1/SvImJ mouse strain is a more suitable murine model to study ARN than C57BL/6 mouse strain.
我们之前已经证明,在一些慢性肾脏病患者中,华法林或达比加群过度抗凝可能导致急性肾损伤,并伴有红细胞(RBC)管型,这种情况被命名为抗凝相关肾病(ARN)。用华法林或达比加群治疗的5/6肾切除(5/6NE)大鼠再现了人类ARN的主要病理特征。我们曾报道,5/6NE C57BL/6小鼠仅部分发生ARN,血清肌酐升高且有血尿,但肾脏中无RBC管型。
本研究旨在调查5/6NE 129S1/SvImJ小鼠是否会发生ARN。
对129S1/SvImJ小鼠进行5/6NE手术。5/6NE术后3周,小鼠接受华法林(1.0和1.5mg/kg/天)或赋形剂治疗7天。每天监测血清肌酐、血尿和凝血酶原时间(PT)。在研究结束时评估肾脏形态。
到第7天时,华法林治疗使PT从基线升高2至3倍(1.0mg/kg/天华法林)和4至5倍(1.5mg/kg/天华法林)。血清肌酐和血尿在第7天时呈剂量依赖性升高。组织学上,8只5/6NE小鼠中有2只(25%)肾小管中有RBC,所有接受华法林治疗的5/6NE 129S1/SvImJ小鼠均有急性肾小管上皮细胞损伤。
我们的研究结果表明,与C57BL/6小鼠品系相比,129S1/SvImJ小鼠品系是研究ARN更合适的小鼠模型。